DIAGNOSTIC AND THERAPEUTIC USE OF RAS-GTPASE-ACTIVATING SH3-DOMAIN-BINDING PROTEIN 2 (G3BP2) FOR NEURODEGENERATIVE DISEASES - Patent 1514118

(19)

(11)

EP 1 514 118 A2

(12)

(88)	Date of publication A3:
	18.03.2004

(43)	Date of publication:
	16.03.2005 Bulletin 2005/11

(21)	Application number: 03740295.5

(22)	Date of filing: 20.06.2003

(51)	International Patent Classification (IPC)⁷: G01N 33/68, C07K 14/47, C12N 15/00, A01K 67/027

(86)	International application number:
	PCT/EP2003/006521

(87)	International publication number:
	WO 2004/001422 (31.12.2003 Gazette 2004/01)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

20.06.2002 EP 02013692
20.06.2002 US 389927 P

(71)	Applicant: EVOTEC Neurosciences GmbH
	22525 Hamburg (DE)

(72)	Inventors:
	VON DER KAMMER, Heinz 22607 Hamburg (DE) POHLNER, Johannes 22175 Hamburg (DE)

(74)	Representative: Meyers, Hans-Wilhelm, Dr.Dipl.-Chem.
	Patentanwältevon Kreisler-Selting-WernerPostfach 10 22 41 50462 Köln 50462 Köln (DE)

(54)	DIAGNOSTIC AND THERAPEUTIC USE OF RAS-GTPASE-ACTIVATING SH3-DOMAIN-BINDING PROTEIN 2 (G3BP2) FOR NEURODEGENERATIVE DISEASES